Importantly, previous reports have demonstrated that inhibition of ARHGDIB in invasive breast cancer cell lines significantly reduces their invasive behavior through regulation of β1-integrin signaling [47]. The gene discussed is ARHGDIB; the disease is breast carcinoma.